Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Proteomic subtypes enrich current acute myeloid leukemia nomenclature and reflect intrinsic pathogenesis alongside aging

Blood (2025) 146 (22): 2681–2695.

https://doi.org/10.1182/blood.2024027692

Published: 2025

Includes: Supplemental data

Journal Articles

Real-world outcomes of glofitamab-based regimens in relapsed/refractory aggressive B-cell lymphoma

Yuhong Ren, Yang Ke, Zhixiang Cheng, Ling Yuan, Weiguang Wang, Jingli Zhuang, Luya Cheng, Yue Wang, Jiadai Xu, Xuejiao Zhang, Jing Li, Peng Liu

Blood (2025) 146 (Supplement 1): 7257.

https://doi.org/10.1182/blood-2025-7257

Published: 2025

Journal Articles

Single-cell tracing of myeloid leukemia evolution in down syndrome reveals a latent progenitor bridging disease onset, progression and relapse

Stephanie Frenz-Wiessner, Yue Wang, Katja Rohde, Giovanni Quinones-Valdez, Hasan Issa, José Gonçalves-Dias, Konstantin Schuschel, Paul Mack, Meng-Wei Ko, Yuanyuan Wang, Feiyang Ma, Kathleen Sakamoto, Vivian Chang, Xinshu Xiao, Jan-Henning Klusmann, Hanna Mikkola

Blood (2025) 146 (Supplement 1): 1472.

https://doi.org/10.1182/blood-2025-1472

Published: 2025

Journal Articles

Homoharringtonine added to CLAG regimen improves outcome of pediatric Relapsed/Refractory AML: A multicenter prospective study

Blood (2025) 146 (Supplement 1): 5219.

https://doi.org/10.1182/blood-2025-5219

Published: 2025

Journal Articles

Practice pattern and outcomes in DLBCL by Genetic Subtypes: Preliminary results from a large-scale real-world study in China

Blood (2025) 146 (Supplement 1): 3689.

https://doi.org/10.1182/blood-2025-3689

Published: 2025

Journal Articles

Blinatumomab following reduced-intensity induction chemotherapy in Chinese children with intermediate- or high-risk B-cell precursor acute lymphoblastic leukemia

Blood (2025) 146 (Supplement 1): 5133.

https://doi.org/10.1182/blood-2025-5133

Published: 2025

Journal Articles

Linperlisib Combined with CHOP Regimen Followed By Autologous Hematopoietic Stem Cell Transplantation and Linperlisib Monotherapy Maintenance for Newly Diagnosed Nodal T-Follicular Helper Cell Lymphoma Patients: A Phase II Trial

Weiping Liu, Yao Liu, Zengjun Li, Shujuan Wen, Zhihua Zhang, Liqun Zou, Ming Jiang, Liping Dou, Ou Bai, Jie Yu, Yue Wang, Jie Chen, Yuqin Song, Jun Zhu

Blood (2024) 144 (Supplement 1): 6389.

https://doi.org/10.1182/blood-2024-199929

Published: 2024

Journal Articles

Safety and Efficacy of Iruplinalkib for Patients with Relapsed or Refractory (r/r) ALK+ Lymphoma: A Phase II Trial

Yue Wang, Fang Wei, Wanli Wang, Linjun Zhao, Jie Chen, Yuqin Song, Jun Zhu, Weiping Liu

Blood (2024) 144 (Supplement 1): 6386.

https://doi.org/10.1182/blood-2024-207002

Published: 2024

Journal Articles

Efficacy and Safety of a New Regime Containing PD1 Antibody and Pegaspargase for Advanced-Stage or Relapsed/Refractory Natural Killer/T Cell Lymphoma

Jie Chen, Linjun Zhao, Chongyang Wu, Haifeng Yu, Zhenling Li, Lihong Liu, Da Gao, Ying Sun, Xiaolei Wei, Yuanbin Wu, Yue Wang, Yuqin Song, Jun Zhu, Weiping Liu

Blood (2024) 144 (Supplement 1): 1686.

https://doi.org/10.1182/blood-2024-207412

Published: 2024

Journal Articles

Integration of Deep Learning in Baseline PET/CT and Multi-Omics Data for Prognostic Modeling in Diffuse Large B-Cell Lymphoma: The Clinicalpet Lymphplex Model

Yue Wang, Xue Wang, Xinyun Huang, Ying Qian, Rongji Mu, Qing Shi, Di Fu, Hongmei Yi, Bin-Shen Ou-Yang, Zhuo Han Li, Shu Cheng, Wang Li, Ning Wen, Pengpeng Xu, Wei Li Zhao

Blood (2024) 144 (Supplement 1): 6224.

https://doi.org/10.1182/blood-2024-206537

Published: 2024

Journal Articles

Practical Microenvironment Classification in Diffuse Large B-Cell Lymphoma Using Digital Pathology

Yuqing Wang, Shuo Wang, Hongmei Yi, Yue Wang, Haimin Xu, Shuang Tian, Yan Dong, Jing Zhao, Di Fu, Rongji Mu, Shuye Wang, Li Wang, Pengpeng Xu, Wei Li Zhao

Blood (2024) 144 (Supplement 1): 4974.

https://doi.org/10.1182/blood-2024-202864

Published: 2024

Journal Articles

Clonal evolution dissection reveals that a high MSI2 level promotes chemoresistance in T-cell acute lymphoblastic leukemia

Blood (2024) 143 (4): 320–335.

https://doi.org/10.1182/blood.2023020490

Published: 2024

Includes: Supplemental data

Journal Articles

Utilization of the Tapestri Platform for Quantification of Single Cell Vector Copy Number in CAR T Cell Products

Lindsey A. Murphy, Alex Li, Saurabh Parikh, Shu Wang, Daniel Mendoza, Khushali Patel, Yilong Yang, Yue Wang, Terry J. Fry, Amanda C. Winters

Blood (2022) 140 (Supplement 1): 4992.

https://doi.org/10.1182/blood-2022-170671

Published: 2022

Journal Articles

Decoding Clonal Evolution in Relapsed T Cell Acute Lymphoblastic Leukemia at Single Cell Resolution

Jingliao Zhang, Yongjuan Duan, Yanxia Chang, Yue Wang, Chao Liu, Ye Guo, Xiaojuan Chen, Li Zhang, Xiaofan Zhu, Yingchi Zhang

Blood (2021) 138 (Supplement 1): 3482.

https://doi.org/10.1182/blood-2021-153299

Published: 2021

Journal Articles

Peripheral Blood Single-Cell Genotyping and Phenotyping in Multiple Myeloma Reveals Shared Mutations across Multiple Hematopoietic Cell Lineages

David G. Coffey, Aditi Agrawal, Maurizio Morri, Edus H. Warren, Robert Durruthy-Durruthy, Marc Arribas-Layton, Yue Wang, Norma F. Neff

Blood (2021) 138 (Supplement 1): 724.

https://doi.org/10.1182/blood-2021-154531

Published: 2021

Journal Articles

The Combination of CUDC-907 and Gilteritinib Shows Promising Antileukemic Activity in Vitro and In Vivo in Preclinical Models of FLT3-ITD AML

Tristan Knight, MD, Xinan Qiao, BS, Jun Ma, Holly Edwards, BS, Lisa Polin, PhD, Juiwanna Kushner, Sijana H Dzinic, PhD, Kathryn White, Hai Lin, MD, Yue Wang, Jeffrey W. Taub, MD, Yubin Ge, PhD

Blood (2019) 134 (Supplement_1): 1262.

https://doi.org/10.1182/blood-2019-123793

Published: 2019

Journal Articles

Direct Oral Anticoagulants As Secondary Prophylaxis in Classical Myeloproliferative Neoplasms

Jacki Day, BS, Allison Deal, MS, Yue Wang, PhD, Benyam Muluneh, PharmD, Daniel Crona, PharmD, PhD, Brandi Reeves, MD

Blood (2018) 132 (Supplement 1): 5468.

https://doi.org/10.1182/blood-2018-99-116713

Published: 2018

Journal Articles

Clonal Trajectories in Persons with Acute Myeloid Leukemia and Normal Cytogenetics Relapsing after Intensive Chemotherapy and after Allotransplants. Does Pretransplant Conditioning Contribute to Mutation Topography?

Ya-Lan Zhou, MD, Li-Xin Wu, Robert Peter Gale, Run-Qing Lu, Jin-Lan Li, Hao Jiang, Qian Jiang, MD, Bin Jiang, Zi-Long Wang, Ting-Ting He, Yue Wang, Xiao-Xiao Zhang, Xiaohui Zhang, MD, Lan-Ping Xu, Kai-Yan Liu, Xiao-Jun Huang, Guorui Ruan

Blood (2018) 132 (Supplement 1): 2813.

https://doi.org/10.1182/blood-2018-99-116592

Published: 2018

Journal Articles

Mutation Topology of Adult B-Cell Acute Lymphoblastic Leukaemia

Li-Xin Wu, Run-Qing Lu, Kai-Yan Liu, Robert Peter Gale, MD ScD, PhD, Qi Zheng, Jiao Zhou, Jin-Lan Li, Shu-Juan Wang, Hao Jiang, MD, Qian Jiang, MD, Bin Jiang, Xiao-Hui Zhang, MD, Lan-Ping Xu, Yue Wang, Cheng-Li Song, Ya-Zhen Qin, Yan-Rong Liu, Xiao-Jun Huang, MD, Guo-Rui Ruan

Blood (2017) 130 (Supplement 1): 3986.

https://doi.org/10.1182/blood.V130.Suppl_1.3986.3986

Published: 2017

Journal Articles

Combination of Venetoclax and CUDC-907 Shows Superior Antileukemic Activity Against Acute Myeloid Leukemia Ex Vivo

Xinyu Li, Jun Ma, Yongwei Su, Jianyun Zhao, Holly Edwards, Yue Wang, Jay Yang, MD, Jeffrey W Taub, MD, Hai Lin, Yubin Ge, PhD

Blood (2016) 128 (22): 1571.

https://doi.org/10.1182/blood.V128.22.1571.1571

Published: 2016

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Proteomic subtypes enrich current acute myeloid leukemia nomenclature and reflect intrinsic pathogenesis alongside aging

Real-world outcomes of glofitamab-based regimens in relapsed/refractory aggressive B-cell lymphoma

Single-cell tracing of myeloid leukemia evolution in down syndrome reveals a latent progenitor bridging disease onset, progression and relapse

Homoharringtonine added to CLAG regimen improves outcome of pediatric Relapsed/Refractory AML: A multicenter prospective study

Practice pattern and outcomes in DLBCL by Genetic Subtypes: Preliminary results from a large-scale real-world study in China

Blinatumomab following reduced-intensity induction chemotherapy in Chinese children with intermediate- or high-risk B-cell precursor acute lymphoblastic leukemia

Linperlisib Combined with CHOP Regimen Followed By Autologous Hematopoietic Stem Cell Transplantation and Linperlisib Monotherapy Maintenance for Newly Diagnosed Nodal T-Follicular Helper Cell Lymphoma Patients: A Phase II Trial

Safety and Efficacy of Iruplinalkib for Patients with Relapsed or Refractory (r/r) ALK+ Lymphoma: A Phase II Trial

Efficacy and Safety of a New Regime Containing PD1 Antibody and Pegaspargase for Advanced-Stage or Relapsed/Refractory Natural Killer/T Cell Lymphoma

Integration of Deep Learning in Baseline PET/CT and Multi-Omics Data for Prognostic Modeling in Diffuse Large B-Cell Lymphoma: The Clinicalpet Lymphplex Model

Practical Microenvironment Classification in Diffuse Large B-Cell Lymphoma Using Digital Pathology

Clonal evolution dissection reveals that a high MSI2 level promotes chemoresistance in T-cell acute lymphoblastic leukemia

Utilization of the Tapestri Platform for Quantification of Single Cell Vector Copy Number in CAR T Cell Products

Decoding Clonal Evolution in Relapsed T Cell Acute Lymphoblastic Leukemia at Single Cell Resolution

Peripheral Blood Single-Cell Genotyping and Phenotyping in Multiple Myeloma Reveals Shared Mutations across Multiple Hematopoietic Cell Lineages

The Combination of CUDC-907 and Gilteritinib Shows Promising Antileukemic Activity in Vitro and In Vivo in Preclinical Models of FLT3-ITD AML

Direct Oral Anticoagulants As Secondary Prophylaxis in Classical Myeloproliferative Neoplasms

Clonal Trajectories in Persons with Acute Myeloid Leukemia and Normal Cytogenetics Relapsing after Intensive Chemotherapy and after Allotransplants. Does Pretransplant Conditioning Contribute to Mutation Topography?

Mutation Topology of Adult B-Cell Acute Lymphoblastic Leukaemia

Combination of Venetoclax and CUDC-907 Shows Superior Antileukemic Activity Against Acute Myeloid Leukemia Ex Vivo

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only